OBJECTIVES: Describing the distribution and clearance of HIV surrogates within the gastrointestinal tract to inform rectal microbicide development. DESIGN: Radiolabeled simulated HIV-infected semen was administered, imaged, and biopsied to simulate and measure colonic HIV distribution after anal intercourse. METHODS: Healthy male subjects with a history of receptive anal intercourse and experience with the use of anal sex toys were recruited to this study. Apheresis isolated leukocytes were collected before simulated intercourse. These autologous leukocytes, radiolabeled with 9.25 MBq (111)Indium-oxine (cell-associated HIV surrogate), and sulfur colloid particles, labeled with 37 MBq (99m)Technectium (cell-free HIV surrogate), were mixed in 3 mL autologous seminal plasma. This simulated HIV-infected semen was administered to subjects via an artificial phallus with urethra after 5 minutes of simulated intercourse. Postdosing dual isotope Single photon emission computed tomography coupled with traditional computed tomography (SPECT/CT) images were acquired at 1, 4, 8, and 24 hours. At 5 hours postdosing, colon biopsies were collected, CD4 cells were extracted, and samples analyzed for radioactivity. RESULTS: SPECT/CT images showed similar luminal distribution for both surrogates, with migration limited to the rectosigmoid colon in all subjects. SPECT showed at least 75% overlap in distribution of both surrogates up to 4 hours after dosing. Biopsies indicate that 2.4% of CD4 cells extracted from rectosigmoid colon tissue were exogenously administered. CONCLUSIONS: Our HIV surrogates stayed within the rectosigmoid colon for 24 hours. Exogenously dosed autologous lymphocytes and HIV-sized particles migrate to similar locations and associate with the colonic tissue in the lumen.
OBJECTIVES: Describing the distribution and clearance of HIV surrogates within the gastrointestinal tract to inform rectal microbicide development. DESIGN: Radiolabeled simulated HIV-infected semen was administered, imaged, and biopsied to simulate and measure colonic HIV distribution after anal intercourse. METHODS: Healthy male subjects with a history of receptive anal intercourse and experience with the use of anal sex toys were recruited to this study. Apheresis isolated leukocytes were collected before simulated intercourse. These autologous leukocytes, radiolabeled with 9.25 MBq (111)Indium-oxine (cell-associated HIV surrogate), and sulfur colloid particles, labeled with 37 MBq (99m)Technectium (cell-free HIV surrogate), were mixed in 3 mL autologous seminal plasma. This simulated HIV-infected semen was administered to subjects via an artificial phallus with urethra after 5 minutes of simulated intercourse. Postdosing dual isotope Single photon emission computed tomography coupled with traditional computed tomography (SPECT/CT) images were acquired at 1, 4, 8, and 24 hours. At 5 hours postdosing, colon biopsies were collected, CD4 cells were extracted, and samples analyzed for radioactivity. RESULTS: SPECT/CT images showed similar luminal distribution for both surrogates, with migration limited to the rectosigmoid colon in all subjects. SPECT showed at least 75% overlap in distribution of both surrogates up to 4 hours after dosing. Biopsies indicate that 2.4% of CD4 cells extracted from rectosigmoid colon tissue were exogenously administered. CONCLUSIONS: Our HIV surrogates stayed within the rectosigmoid colon for 24 hours. Exogenously dosed autologous lymphocytes and HIV-sized particles migrate to similar locations and associate with the colonic tissue in the lumen.
Authors: C W Hendrix; E J Fuchs; K J Macura; L A Lee; T L Parsons; R P Bakshi; W A Khan; A Guidos; J P Leal; R Wahl Journal: Clin Pharmacol Ther Date: 2007-05-16 Impact factor: 6.875
Authors: Beryl A Koblin; Marla J Husnik; Grant Colfax; Yijian Huang; Maria Madison; Kenneth Mayer; Patrick J Barresi; Thomas J Coates; Margaret A Chesney; Susan Buchbinder Journal: AIDS Date: 2006-03-21 Impact factor: 4.177
Authors: Ying J Cao; Brian S Caffo; Edward J Fuchs; Linda A Lee; Yong Du; Liye Li; Rahul P Bakshi; Katarzyna Macura; Wasif A Khan; Richard L Wahl; Lisa A Grohskopf; Craig W Hendrix Journal: Br J Clin Pharmacol Date: 2012-12 Impact factor: 4.335
Authors: Nicole A Pescatore; Rebecca Pollak; Colleen S Kraft; Jennifer G Mulle; Colleen F Kelley Journal: AIDS Res Hum Retroviruses Date: 2018-02-07 Impact factor: 2.205
Authors: Francisco Leyva; Edward J Fuchs; Rahul Bakshi; Alex Carballo-Dieguez; Ana Ventuneac; Chen Yue; Brian Caffo; Yong Du; Michael Torbenson; Liye Li; Gerald Mullin; Linda Lee; Lisa Rohan; Peter A Anton; Craig W Hendrix Journal: AIDS Res Hum Retroviruses Date: 2015-07-08 Impact factor: 2.205
Authors: Laura M Ensign; Andreas Henning; Craig S Schneider; Katharina Maisel; Ying-Ying Wang; Marc D Porosoff; Richard Cone; Justin Hanes Journal: Mol Pharm Date: 2013-05-23 Impact factor: 4.939
Authors: Ethel D Weld; Hiwot Hiruy; Kate Morrow Guthrie; Joseph L Fava; Sara E Vargas; Karen Buckheit; Robert Buckheit; Hans Spiegel; Jennifer Breakey; Edward J Fuchs; Craig W Hendrix Journal: AIDS Res Hum Retroviruses Date: 2016-12-13 Impact factor: 2.205